QUARTERLY FINANCIAL DATA (UNAUDITED)

12 Months Ended

Jun. 30, 2013

QUARTERLY FINANCIAL DATA (UNAUDITED)

QUARTERLY FINANCIAL DATA (UNAUDITED)

15. QUARTERLY FINANCIAL DATA (UNAUDITED)

        Summarized quarterly data for fiscal years 2013 and 2012 follows:

	Quarter Ended
	September 30(e)		December 31			March 31		June 30(f)			Year Ended
	(Dollars in thousands, except per share amounts)
2013
Revenues	$	505,360	$	506,165		$	504,937	$	502,251		$	2,018,713
Cost of service and product revenues, excluding depreciation and amortization		285,660		289,329			287,597		296,678			1,159,264
Operating income (loss)(a)		9,273		8,723			3,308		(8,978	)		12,326
Income (loss) from continuing operations(a)(b)		34,647		(16,119	)		896		(15,258	)		4,166
Income from discontinued operations(c)		3,777		3,853			1,465		15,933			25,028
Net income (loss)(a)(b)(c)		38,424		(12,266	)		2,361		675			29,194
Income (loss) from continuing operations per share, basic		0.60		(0.28	)		0.02		(0.27	)		0.07
Income from discontinued operations per share, basic(d)		0.07		0.07			0.03		0.28			0.44
Net income (loss) per basic share(d)		0.67		(0.22	)		0.04		0.01			0.51
Income (loss) from continuing operations per share, diluted(d)		0.54		(0.28	)		0.02		(0.27	)		0.07
Income from discontinued operations per share, diluted		0.06		0.07			0.03		0.28			0.44
Net income (loss) per diluted share(d)		0.59		(0.22	)		0.04		0.01			0.51
Dividends declared per share		0.06		0.06			0.06		0.06			0.24

Refer to Management's Discussion and Analysis of Financial Condition and Results of Operations in Part II, Item 7 in this Form 10-K for explanations of items, which impacted fiscal year 2013 revenues, operating and net income (loss).

	Quarter Ended
	September 30		December 31			March 31			June 30			Year Ended
	(Dollars in thousands, except per share amounts)
2012
Revenues	$	531,346	$	526,138		$	535,901		$	528,842		$	2,122,227
Cost of service and product revenues, excluding depreciation and amortization		288,688		288,399			296,277			289,942			1,163,306
Operating income (loss)(a)		9,004		11,936			22,950			(46,057	)		(2,167	)
Income (loss) from continuing operations(a)(b)		5,622		11,900			(3,878	)		(65,387	)		(51,743	)
Income (loss) from discontinued operations(c)		2,715		(69,327	)		2,509			1,753			(62,350	)
Net income (loss)(a)(b)(c)		8,337		(57,427	)		(1,369	)		(63,634	)		(114,093	)
Income (loss) from continuing operations per share, basic		0.10		0.21			(0.07	)		(1.14	)		(0.91	)
Income (loss) from discontinued operations per share, basic		0.05		(1.22	)		0.04			0.03			(1.09	)
Net income (loss) per basic share(d)		0.15		(1.01	)		(0.02	)		(1.11	)		(2.00	)
Income (loss) from continuing operations per share, diluted		0.10		0.20			(0.07	)		(1.14	)		(0.91	)
Income (loss) from discontinued operations per share, diluted		0.05		(1.01	)		0.04			0.03			(1.09	)
Net income (loss) per diluted share(d)		0.15		(0.81	)		(0.02	)		(1.11	)		(2.00	)
Dividends declared per share		0.06		0.06			0.06			0.06			0.24

Refer to Management's Discussion and Analysis of Financial Condition and Results of Operations in Part II, Item 7 in this Form 10-K for explanations of items, which impacted fiscal year 2012 revenues, operating and net income.

(a)

During the fourth quarter of fiscal year 2013, the Company recorded a $12.6 million ($7.7 million net of tax) inventory reserve associated with the Company's implementation of standardized plan-o-grams in fiscal year 2014. During the fourth quarter of fiscal year 2012, the Company recorded a goodwill impairment charge of $67.7 million ($55.2 million net of tax).

(b)

During the first quarter of fiscal year 2013, the Company recorded a $32.2 million net of tax foreign currency gain associated with the sale of Provalliance. During the second quarter of fiscal year 2013, the Company recorded a $17.9 million impairment charge net of tax related to the impairment of EEG. During the fourth quarter of fiscal year 2013, the Company incurred $6.7 million net of tax of expense for a make-whole payment associated with the prepayment of debt. Expense of $17.2 million net of tax was recorded during fiscal year 2012 related to the impairment of our investment in Provalliance. Expense of $19.4 million net of tax was recorded during fiscal year 2012 related to the impairment of our investment in EEG.

(c)

During the fourth quarter of fiscal year 2013, the Company recorded a $15.4 million gain, net professional and transaction fees and taxes, associated with the disposition of Hair Club. During the second quarter of quarter of fiscal year 2012, the Company recorded a goodwill impairment charge of $72.6 million net of tax.

(d)

Total is an annual recalculation; line items calculated quarterly may not sum to total.

(e)

As filed within the 10-Q/A for the period ended September 30, 2012.

(f)

During the fourth quarter of fiscal year 2013, the Company identified certain errors that related to prior periods.  The errors related to an understatement of interest expense and certain uncertain tax positions in prior periods.  Because these errors are not material to the Company's consolidated financial statements for any prior periods, the current year fourth quarter, or fiscal 2013, the Company recorded a cumulative adjustment to correct the errors during the fourth quarter of fiscal 2013.  The impact of these items on the Company's Consolidated Statement of Operations increased interest expense by $0.4 million, increased income tax expense by $0.3 million and decreased net income by $0.7 million.